Cargando…
Monocytes-Derived Macrophages Mediated Stable Expression of Human Brain-Derived Neurotrophic Factor, a Novel Therapeutic Strategy for NeuroAIDS
HIV-1 associated dementia remains a significant public health burden. Clinical and experimental research has shown that reduced levels of brain-derived neurotrophic factor (BDNF) may be a risk factor for neurological complications associated with HIV-1 infection. We are actively testing genetically...
Autores principales: | Tong, Jing, Buch, Shilpa, Yao, Honghong, Wu, Chengxiang, Tong, Hsin-I, Wang, Youwei, Lu, Yuanan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3914783/ https://www.ncbi.nlm.nih.gov/pubmed/24505242 http://dx.doi.org/10.1371/journal.pone.0082030 |
Ejemplares similares
-
Lentiviral vector-mediated stable expression of sTNFR-Fc in human macrophage and neuronal cells as a potential therapy for neuroAIDS
por: Cao, Shengbo, et al.
Publicado: (2011) -
Proceedings of the ISEV symposium on “HIV, NeuroAIDS, drug abuse & EVs”
por: Hu, Guoku, et al.
Publicado: (2017) -
Contribution of CNS cells in NeuroAIDS
por: Verma, Ashish Swarup, et al.
Publicado: (2010) -
Minocycline Inhibition of Monocyte Activation Correlates with Neuronal Protection in SIV NeuroAIDS
por: Campbell, Jennifer H., et al.
Publicado: (2011) -
HIV-Tat regulates macrophage gene expression in the context of neuroAIDS
por: Carvallo, Loreto, et al.
Publicado: (2017)